Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 47
Titolo Data di pubblicazione Autore(i) File
Disease stabilization as a surrogate end point in advanced non small cell lung cancer patients treated with erlotinib or gefitinib 1-gen-2007 Grossi, Francesco; Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P.
Gefitinib treatment outcome after progression on erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) 1-gen-2007 Defferrari, C; Brianti, A; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P; Grossi, Francesco
Skin toxicities difference between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC) 1-gen-2007 Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Grossi, Francesco; Pronzato, P.
Difference in skin toxicity incidence between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC) 1-gen-2008 Grossi, Francesco; Defferrari, C; Brianti, A; Dal Bello, Mg; Catania, Gianluca; Pronzato, P.
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients 1-gen-2013 Puzone, R.; Savarino, G.; Salvi, S.; Dal Bello, M. G.; Barletta, G.; Genova, C.; Rijavec, E.; Sini, C.; Esposito, A. I.; Ratto, G. B.; Truini, M.; Grossi, F.; Pfeffer, U.
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 1-gen-2014 Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F.
Looking for results in non-small-cell lung cancer: Is bio-chemotherapy the right answer? 1-gen-2014 Genova, C.; Rijavec, E.; Grossi, F.
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer 1-gen-2014 Alama, A.; Truini, A.; Coco, S.; Genova, C.; Grossi, F.
Afatinib for the treatment of non-small cell lung cancer 1-gen-2015 Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F.
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 1-gen-2016 Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F.
Hematopoietic growth factors in lung cancer 1-gen-2016 Genova, C.; Rijavec, E.; Grossi, F.
Vinflunine for the treatment of non-small cell lung cancer 1-gen-2016 Genova, C.; Alama, A.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Vanni, I.; Biello, F.; Barletta, G.; Rossi, G.; Grossi, F.
Recent advances in squamous non-small cell lung cancer: Evidence beyond predictive biomarkers 1-gen-2016 Genova, C.; Rijavec, E.; Grossi, F.
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy 1-gen-2016 Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco
Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage? 1-gen-2017 Genova, C.; Rijavec, E.; Grossi, F.
Understanding the checkpoint blockade in lung cancer immunotherapy 1-gen-2017 Dal Bello, M. G.; Alama, A.; Coco, S.; Vanni, I.; Grossi, F.
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 1-gen-2017 Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy 1-gen-2017 Grossi, F.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Maggioni, C.; Burrafato, G.; Sini, C.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J.
Exosomes: a new horizon in lung cancer 1-gen-2017 Vanni, I.; Alama, A.; Grossi, F.; Dal Bello, M. G.; Coco, S.
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 1-gen-2017 Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F.
Mostrati risultati da 1 a 20 di 47
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile